Rectal Cancer
Conditions
Keywords
eLAPE,, perineum,, pelvic floor reconstruction
Brief summary
This is a prospective, multicenter, single arm, observational pilot study to assess the clinical outcomes of Strattice Reconstructive Tissue Matrix for perineal reconstruction following eLAPE and simultaneous stoma reinforcement.
Detailed description
About 40 subjects will be enrolled from 4 centers over approx 24 months. Subjects will all be undergoing extralevator abdominoperineal excision with concomitant ostomy creation.
Interventions
Perineal reconstruction and stoma reinforcement with Strattice
Sponsors
Study design
Eligibility
Inclusion criteria
* Primary cancers undergoing curative surgery (R0) * Life expectancy \> 2 yrs * Neoadjuvant radiotherapy with or without chemotherapy
Exclusion criteria
* Pelvic extenteration or extended resections * Previously irradiated patients (i.e. radiation therapy for a previous cancer) * Co-morbidities of: systemic infection, chronic liver failure, chronic renal failure, HIV, Hepatitis C, other advanced/metastatic cancer, collagen disorder * sensitivity to porcine derived products or polysorbate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perineal wound healing | 12 months | Perineal wound healing will be assessed using the Southamptom Wound Scoring System and perineal pain assessed using a visual analogue scale (VAS) daily during hospital stay and then POD 7, 30 and months 3, 6 and 12. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of perineal herniation | 24 months | Incidence of perineal hernia |
| Incidence of parastomal hernia | 24 months | Stoma will be assessed for herniation at Months 3, 6, 12 and 24 |
Countries
Denmark, Sweden, United Kingdom